which the Company had invested since January 2017. Cost of Sales and Gross Profit Unit : THB mm Unless otherwise stated For the year ended 31 December 2017 2016 Total sales 723.96 606.38 Cost of sales

residual value of assets and the revenue from fuel tank rental services. 1.2 Expenses 1.2.1 Cost of services In Q1/2019, Cost of services was of Bt387.7 million, increased by Bt9.5 million or 2.5%(y-o-y

decreased lease receivable, calculated according to the Effective Interest Method. 2.4 Cost of sales and rendering of services (excluding fuel costs) Cost of sales and rendering of services for the 2 nd

, The Company’s strategies such as increasing more specialty cilinics, medical instruments and expanding into new market so as to drive a sustainable growth Cost of Hospital Operations The costs of

30.69 1.90 6.21 Total revenue 1,151,091 1,374,128 (223,037) (16.23) 2,970,715 2,646,863 323,852 12.24 Total Cost & Expenses 1,013,853 1,243,461 (229,608) (18.47) 2,699,583 2,466,406 233,177 9.45 Selling

. Rathian Srimongkol as the Vice Chairman of the Board of Directors, effective from 12 October 2018. Appointed Prof. Dr. Surakiat Sathirathai as the Chairman of the Board of Directors and appointed Mr. Lee

record high depreciation cost in full which did not correspond to such low utilization of production and machinery. The Company engaged independent engineering expert to inspect and appraise the assets and

other expenses were 2,035 million baht, increased by 112 million baht or 6% y-y due to increase of advertising expense 55% y-y. However, the Company still maintained effective operating cost control with

88 million baht or 5% y-y and 3% q-q. However, the Company still maintained effective operating cost control with cost to income ratio at 35% of total revenues. Considering the Company’s separate

improved following on-going cost optimization and FY17 guidance maintained. AIS reported 3Q17 EBITDA of Bt17,589mn, +15% YoY and +2.8% QoQ, mainly due to revenue growth and controlled SG&A. YTD, AIS spent